Despite bone scintigraphy plays an important role in the diagnostic process of patients with prostate cancer, it has low sensitivity in patients with values of prostate-specific antigen (PSA) <20 ng/ml and relatively low specificity [20]. This evidence concerns the gene KLK3 and prostate cancer.